目的分析先天性无虹膜病一家系的临床表现及其致病原因,并分析候选变异对蛋白结构的影响。
方法采用家系调查研究方法,收集2023年6月于河南省立眼科医院就诊的中国河南地区汉族先天性无虹膜病一家系2代3人的临床资料,其中患者1例。详细询问患者及其家系成员病史,并进行全面眼科检查,包括视力、眼压、眼前节照相、彩色眼底照相、超声生物显微镜、光学相干断层扫描等。采集该家系成员外周血,对患者进行全外显子组测序,其他成员采用Sanger测序验证。对新发现的变异位点进行致病性和蛋白结构分析。
结果先证者男,23岁,双眼视力较差、无虹膜、角膜变性、晶状体轻度混浊、前房较浅且眼压高、周边视网膜变性、黄斑发育不良。先证者父母临床表型未见明显异常。全外显子组测序显示, PAX6基因外显子10存在移码和无义变异c.734_735del(p.Arg245Asnfs*20),该变异为第734~735位碱基缺失,导致其245位精氨酸变异为天冬酰胺,并在其后19个氨基酸处提前出现终止密码子。该变异在HGMD、Clinvar、千人基因组和gnomAD数据库均未见收录。先证者父母未携带该变异,符合家系共分离。通过SMART工具进行亚结构鉴定发现该变异位于HOX结构域中。氨基酸保守性分析发现 PAX6基因翻译的氨基酸序列第245位精氨酸在人、小家鼠、家犬、非洲爪蟾、猕猴等物种中高度保守。经ACMG《序列变异解读标准和指南》评估,该变异被分类为致病性变异(PVS1+PS2+PM2+PP3)。蛋白结构分析显示,PAX6蛋白的同源结构域和富含脯氨酸-丝氨酸-苏氨酸的结构域缺失。
结论 PAX6基因新发移码和无义致病性变异c.734_735del(p.Arg245Asnfs*20)是该先天性无虹膜病家系的致病变异位点,该变异使PAX6蛋白同源结构域和富含脯氨酸-丝氨酸-苏氨酸的结构域缺失。
ObjectiveTo analyze the clinical manifestations and explore the etiology in a family with congenital aniridia and to analyze the influence of candidate variants on the protein structure.
MethodsA pedigree investigation was performed.A Han Chinese family with congenital aniridia of two generations consisting of three members from Henan Province, including one patient diagnosed with congenital aniridia, was identified and studied following their admission to Henan Eye Hospital in June 2023.A thorough medical history was obtained for the patient and their family members.Comprehensive ophthalmologic examinations were conducted, including visual acuity, intraocular pressure, anterior segment photography, color fundus photography, ultrasound biomicroscopy, and optical coherence tomography, etc.Peripheral blood samples were obtained from the family members and whole exome sequencing (WES) was performed on the patient and validated by Sanger sequencing for other members.The pathogenicity and protein structure of newly identified variant sites were analyzed.This study adhered to the Declaration of Helsinki.The study protocol was approved by the Ethics Committee of Henan Eye Hospital (No.HNEECKY-2023[06]).Written informed consent was obtained from each subject.
ResultsThe proband is a 23-year-old male presenting with poor binocular vision, aniridia, corneal degeneration, mild lens opacity, shallow anterior chamber, elevated intraocular pressure, peripheral retinal degeneration, and macular dysplasia.The clinical phenotype of the proband's parents did not show any significant abnormality.WES identified a heterozygous frameshift and nonsense varint c. 734_735del (p.Arg245Asnfs*20) in exon 10 of the PAX6 gene, which consisited of two bases deletion at positions 734 to 735, resulting in the mutation of its arginine at position 245 to asparagine and the early appearance of a termination codon at the next 19 amino acids.The variant had not been identified in the HGMD, Clinvar, 1 000 Genomes, and gnomAD databases.Neither of the proband's parents carried the variant, consistent with the pattern of family co-segregation.Substructural analysis using the SMART tool indicated that the variant is situated within the HOX domain.Amino acid conservation analysis demonstrated that the arginine residue at position 245 in the PAX6 gene is highly conserved across multiple species, including human, house mouse, domestic dog, African clawed frog, and macaque.The variant was classified as pathogenic (PVS1+ PS2+ PM2+ PP3) based on the ACMG standards and guidelines for the interpretation of sequence variants.Protein structure analysis revealed the absence of both the homologous domain and the proline-serine-threonine-rich domain in the PAX6 protein.
ConclusionsA novel pathogenic variant, c.734_735del (p.Arg245Asnfs*20), in the PAX6 gene has been identified in a family affected by congenital aniridia.This variant results in the deletion of both the PAX6 protein homology domain and the proline-serine-threonine-rich domain.
王冬冬,杜娇,黄子旭,等. PAX6新发移码和无义变异导致中国先天性无虹膜病一家系临床表型和基因型分析 [J]. 中华实验眼科杂志,2024,42(10):927-931.
DOI:10.3760/cma.j.cn115989-20240613-00151版权归中华医学会所有。
未经授权,不得转载、摘编本刊文章,不得使用本刊的版式设计。
除非特别声明,本刊刊出的所有文章不代表中华医学会和本刊编委会的观点。
王冬冬:酝酿和设计试验、实施研究、分析数据、起草及修改文章;杜娇:实施研究、收集数据、绘制图片;黄子旭:采集数据、起草文章;但汉东:修改文章;林作鹏:分析蛋白结构;宋宗明:酝酿和设计试验、对文章的知识性内容作批评性审阅及定稿

你好,我可以帮助您更好的了解本文,请向我提问您关注的问题。